H. Lenk

发表

Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria

A. Ganser, J. Oldenburg, R. Klamroth, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Impact of inhibitor epitope profile on the neutralizing effect against plasma‐derived and recombinant factor VIII concentrates in vitro

J. Astermark, J. Voorberg, E. Berntorp, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

The German National Immune Tolerance Registry, 1997 Update

H. Lenk, 1999, Vox Sanguinis.

Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates

J. Oldenburg, K. Kurnik, M. Depka, 2005, Annals of the New York Academy of Sciences.

The German Registry of immune tolerance treatment in hemophilia--1999 update.

H. Lenk, 2000, Haematologica.

Health status and health‐related quality of life of children with haemophilia from six West European countries

M. Bullinger, G. Auerswald, K. Khair, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[Iliopsoas hemorrhage in hemophilic children].

H. Lenk, G. Weissbach, M. Domula, 1985, Folia haematologica.

MRI Staging of Hemophilic Joints in Comparison with the Radiological Score and the Clinical Dates of Children and Young Adults

H. Lenk, D. Weber, F. Schmidt, 2005 .

Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany

K. Kurnik, W. Schramm, G. Auerswald, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia B and other bleeding disorders

J. Oldenburg, S. Rost, V. Ivaškevičius, 2000 .

Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization

J. Oldenburg, R. Schwaab, H. Lenk, 2004, Thrombosis and Haemostasis.

Inhibitor Incidence in Previously Untreated Patients (PUPs) with Hemophilia A and B. A Prospective Multi-Center Study of the Pediatric Committee of the German, Swiss and Austrian Society for Thrombosis and Hemostasis Research (GTH)

G. Auerswald, W. Kreuz, H. Lenk, 2006 .

Inhibitors in German Hemophilia A Patients Treated with a Double Virus Inactivated Factor VIII Concentrate Bind to the C2 Domain of FVIII Light Chain

H. Brackmann, H. Lenk, M. Di Giambattista, 1999, Thrombosis and Haemostasis.

Detection of all anti‐factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay

G. Auerswald, W. Kreuz, H. Lenk, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.

J. Vermylen, J. Saint-Remy, H. Lenk, 1996, The Journal of clinical investigation.

Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.

G. Auerswald, W. Kreuz, H. Lenk, 2001 .

Haemophilia A

S. Rost, V. Ivaškevičius, J. Luboshitz, 2000 .

When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study

H. Lenk, A. Müller, F. Kertzscher, 1999, European Journal of Pediatrics.

Frequency of different types of von Willebrand's disease in the GDR.

H. Lenk, I. Nilsson, L. Holmberg, 2009, Acta medica Scandinavica.

[Haemophilia treatment centres in Germany].

H. Pollmann, B. Eifrig, H. Lenk, 2012, Hamostaseologie.

Bladder exstrophy and Epstein type congenital macrothrombocytopenia: Evidence for a common cause?

J. Martignetti, A. Difeo, J. Dötsch, 2006, American journal of medical genetics. Part A.

Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden

H. Lenk, E. Scheibel, I. Nilsson, 1992, British journal of haematology.

THE PROGRESSIVE ANTITHROMBIN ACTIVITY AND ITS RELATIONS TO OTHER FACTORS OF THE COAGULATION SYSTEM IN NEWBORNS

H. Lenk, G. Weissbach, P. Schneider, 1974, Acta paediatrica Scandinavica.

Acute portal vein thrombosis after splenic embolization and splenectomy for autoimmune pancytopenia.

H. Lenk, I. Sorge, R. Tröbs, 2005, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[Blood coagulation tests in children with cyanotic heart defects].

H. Lenk, G. Weissbach, M. Domula, 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: Is there a clinical relevance?

H. Lenk, A. Müller, F. Kertzscher, 1999, European Journal of Pediatrics.

Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function

A. Biswas, J. Oldenburg, P. Petrides, 2010, Haematologica.

Spurenelemente - Analytik, Umsatz, Bedarf Mangel und Toxikologie - Symposium in Bad Kissingen 1977

J. M. Munoz, H. Bremer, G. Pahlke, 1979 .

Molecular biology and clinical manifestation of hereditary factor VII deficiency.

G. Marx, H. Losonczy, W. Kreuz, 2000, Seminars in Thrombosis and Hemostasis.

IIB von W illebr and' s disease : mutations and clinical presentation in nine families Denmark, Germany and Sweden

B. Dahlbäck, H. Lenk, E. Scheibel, 1992 .

Clinical Course and Laboratory Findings in a Patient with a New Mutation Causing Wiskott-Aldrich Syndrome

U. Sack, A. Meindl, V. Schuster, 2002 .

Course of Inhibitors in mild Hemophilia A with and without Immune Tolerance Treatment

H. Lenk, F. Kertzscher, 2002 .

Localization and Characterization of Mutations Within the Factor VIII Gene in a Cohort of 212 Patients with Hemophilia A

J. Oldenburg, S. Rost, R. Schwaab, 2001 .

Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-Trimoxazole

H. Lenk, V. Kiefel, F. Kertzscher, 1999, European Journal of Pediatrics.

Haemophilia A

S. Rost, V. Ivaškevičius, J. Luboshitz, 2000 .

German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies

W. Kreuz, H. Brackmann, G. Auerswald, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor Incidence in Previously Untreated Patients (PUP) with Hemophilia A and B - a 10-Year-Follow up of the Prospective Multicenter Study.

W. Kreuz, G. Auerswald, H. Lenk, 2004 .